Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stommel

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Nature Genetics|September 6, 2000
A transactivation-deficient mouse model provides insights into Trp53 regulation and functionG S Jimenez, M Nister, J M Stommel, et al.
Oncogene|March 26, 2025
Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancerXuejiao Zhao, Huiling Lai, Guannan Li, et al.
Oncotarget|January 25, 2017
Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastomaDiane M Kambach, Alan S Halim, A Gesine Cauer, et al.
Molecular Cell|September 5, 2017
Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break ResponseJoshua R Porter, Brian E Fisher, Laura Baranello, et al.
Science (New York, N.Y.)|September 18, 2007
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapiesJayne M Stommel, Alec C Kimmelman, Haoqiang Ying, et al.
JCO Precision Oncology|June 21, 2024
Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 ExpressionBen L Kong, Jayne M Stommel, Jamie M Keck, et al.
Genes & Development|November 3, 2007
Malignant astrocytic glioma: genetics, biology, and paths to treatmentFrank B Furnari, Tim Fenton, Robert M Bachoo, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Genes & Development|March 17, 2011
Pancreatic cancers require autophagy for tumor growthShenghong Yang, Xiaoxu Wang, Gianmarco Contino, et al.
Molecular Cancer Research : MCR|June 18, 2026
Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunitiesJamie M Keck, Limin Zhu, Jayne M Stommel, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Nature Genetics|September 6, 2000
A transactivation-deficient mouse model provides insights into Trp53 regulation and functionG S Jimenez, M Nister, J M Stommel, et al.
Oncogene|March 26, 2025
Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancerXuejiao Zhao, Huiling Lai, Guannan Li, et al.
Oncotarget|January 25, 2017
Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastomaDiane M Kambach, Alan S Halim, A Gesine Cauer, et al.
Molecular Cell|September 5, 2017
Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break ResponseJoshua R Porter, Brian E Fisher, Laura Baranello, et al.
Science (New York, N.Y.)|September 18, 2007
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapiesJayne M Stommel, Alec C Kimmelman, Haoqiang Ying, et al.
JCO Precision Oncology|June 21, 2024
Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 ExpressionBen L Kong, Jayne M Stommel, Jamie M Keck, et al.
Genes & Development|November 3, 2007
Malignant astrocytic glioma: genetics, biology, and paths to treatmentFrank B Furnari, Tim Fenton, Robert M Bachoo, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Genes & Development|March 17, 2011
Pancreatic cancers require autophagy for tumor growthShenghong Yang, Xiaoxu Wang, Gianmarco Contino, et al.
Molecular Cancer Research : MCR|June 18, 2026
Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunitiesJamie M Keck, Limin Zhu, Jayne M Stommel, et al.
Pageof 7